News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Raffaele Colombo: Another EGFR and HER3 bispecific ADC will start clinical development in China
Raffaele Colombo/LinkedIn
Jan 13, 2025, 13:44

Raffaele Colombo: Another EGFR and HER3 bispecific ADC will start clinical development in China

Rafaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X:

“And another EGFRxHER3 bispecific ADC will start clinical development in China!

JS212, developed by Shangai Junshi Biosciences.”

Raffaele Colombo: Another EGFR and HER3 bispecific ADC will start clinical development in China

Earlier this week Raffaele Colombo shared on X:

“Avenzo Therapeutics licensed DualityBio’s preclinical bispecific ADC DB-1418 (= AVZO-1418)

bispecific EGFRxHER3, 1+1 format
P1021 payload (topo1i), DAR=6

Phase 1 expected to start this year.”

Raffaele Colombo: Another EGFR and HER3 bispecific ADC will start clinical development in China

Raffaele Colombo, a leading figure in the pharmaceutical industry is the Associate Director of Medicinal Chemistry at Zymeworks Inc.. His leadership and scientific acumen drive the discovery and optimization of novel drug candidates and advance the treatment landscape for various diseases.

cancer EGFR and HER3 bispecific ADC OncoDaily Oncology Raffaele Colombo Shangai Junshi Biosciences
Special Coverage
Science
Jan 14, 2025, 19:05
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Societies
Jan 14, 2025, 19:03
Become a CancerX 2025 Accelerator Mentor
Blog
Jan 14, 2025, 18:58
Professor Tak Mak shares the story behind his discovery of the T Cell Receptor - SPCC
Science
Jan 14, 2025, 18:51
Abi Siva: Another step close to De-escalation
Science
Jan 14, 2025, 18:49
Naveen Pemmaraju: Addition of navitoclax to ruxolitinib for patients with myelofibrosis
Blog
Jan 14, 2025, 18:47
Zeena Salman: Five-year anniversary working with St. Jude Children's Research Hospital
Dialogues
Jan 14, 2025, 18:45
United by Unique: Centering Care Around People and Their Stories
Blog
Jan 14, 2025, 18:40
Anna Rathkopf: Learning about Breast Density after a cancer diagnosis
Blog
Jan 14, 2025, 18:40
GSK has announced agreement to acquire the U.S. biotech firm IDRx for up to $1.15 billion
Blog
Jan 14, 2025, 18:30
Keynote Lecture by Pamela Kunz to Highlight Need for Inclusive Science in GI Cancers - ASCO
Blog
Jan 14, 2025, 18:21
Applications are open for the LUNGevity Research Awards
Insight
Jan 14, 2025, 18:15
James Crowley: ctDNA Origins, Cancer Biology and Clinical Study Needs